AU2003207639A1 - Pyrimidine derivatives as rho-kinase inhibitors - Google Patents

Pyrimidine derivatives as rho-kinase inhibitors

Info

Publication number
AU2003207639A1
AU2003207639A1 AU2003207639A AU2003207639A AU2003207639A1 AU 2003207639 A1 AU2003207639 A1 AU 2003207639A1 AU 2003207639 A AU2003207639 A AU 2003207639A AU 2003207639 A AU2003207639 A AU 2003207639A AU 2003207639 A1 AU2003207639 A1 AU 2003207639A1
Authority
AU
Australia
Prior art keywords
rho
kinase inhibitors
pyrimidine derivatives
pyrimidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003207639A
Inventor
Samir Bennabi
Stephen Boyer
Jacques Dumas
Achim Feurer
Holia Hatoum-Mokdad
Dhanapalan Nagarathnam
Hans Pluempe
Chunguang Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharmaceuticals Corp
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Publication of AU2003207639A1 publication Critical patent/AU2003207639A1/en
Abandoned legal-status Critical Current

Links

AU2003207639A 2002-01-23 2003-01-23 Pyrimidine derivatives as rho-kinase inhibitors Abandoned AU2003207639A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/349,987 2002-01-23

Publications (1)

Publication Number Publication Date
AU2003207639A1 true AU2003207639A1 (en) 2003-09-02

Family

ID=

Similar Documents

Publication Publication Date Title
AU2003278088A1 (en) Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
AU2003260345A1 (en) 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
PL372756A1 (en) Nicotinamide derivatives useful as pde4 inhibitors
IL165515A0 (en) Bisindolyl-maleimid derivatives as kinase inhibitors
AU2003249442A1 (en) Kinase inhibitors
AU2003222055A1 (en) Kinase inhibitors
AU2003286711A1 (en) Indazolinone compositions useful as kinase inhibitors
AU2003255376A1 (en) Piperidine-derivatives as pde4 inhibitors
AU2003202263A1 (en) Roh-kinase inhibitors
AU2002303892A1 (en) 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
HK1071360A1 (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
AU2003293356A1 (en) Dihydropyridinone derivatives as hne inhibitors
AU2003281477A1 (en) 4-amino-substituted pyrimidine derivatives
AU2003237446A1 (en) Pyrazole-derivatives as p38 kinase inhibitors
IL172793A0 (en) Nicotinamide derivatives useful as pde4 inhibitors
AU2003202116A1 (en) Nicotinamide derivatives useful as pde4 inhibitors
AU2003302238A1 (en) 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
GB0317516D0 (en) Nicotinamide derivatives useful as PDE4 inhibitors
AU2003249535A1 (en) 1,6-fused uracil derivatives as matrix metalloproteinase inhibitors
AU2003302588A1 (en) Phosphodiesterase 10a inhibitors
GB0317482D0 (en) Nicotinamide derivatives useful as pde4 inhibitors
GB0317484D0 (en) Nicotinamide derivatives useful as pde4 inhibitors
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
AU2003268464A1 (en) INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE